Evanston Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSCI
Invesco BulletShares 2018 Corporate Bond ETF
BSCI
|
+$24.6M |
| 2 |
AT&T
T
|
+$7.69M |
| 3 |
Viatris
VTRS
|
+$7.63M |
| 4 |
Corning
GLW
|
+$7.54M |
| 5 |
Amgen
AMGN
|
+$7.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$8.07M |
| 2 |
HOLX
Hologic
HOLX
|
+$7.88M |
| 3 |
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
|
+$7.39M |
| 4 |
Verizon
VZ
|
+$7.33M |
| 5 |
Gilead Sciences
GILD
|
+$6.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.71% |
| 2 | Financials | 8.61% |
| 3 | Healthcare | 8.52% |
| 4 | Industrials | 7.38% |
| 5 | Consumer Discretionary | 6.65% |
Similar funds
Evanston Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Evanston Advisors held 73 positions worth $407M, up 10% from $369M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Evanston Advisors deployed $41.8M of net new capital in Q2 2017, opening 13 new positions and adding to 46 existing holdings. Its largest new stake was Viatris: 198,755 shares worth $7.72M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Guggenheim BulletShares 2017 Corporate Bond ETF, an estimated $742K trimmed.
- Evanston Advisors's largest Q2 2017 buy was Viatris: 198,755 shares worth $7.72M.
- Evanston Advisors added most to Invesco BulletShares 2018 Corporate Bond ETF in Q2 2017, an estimated $24.6M increase.
- Evanston Advisors's biggest Q2 2017 reduction was Guggenheim BulletShares 2017 Corporate Bond ETF, cutting an estimated $742K.
- Evanston Advisors fully exited Lam Research in Q2 2017, selling an estimated $8.07M.
- Evanston Advisors's ten largest holdings make up 40% of its $407M portfolio in Q2 2017.
- Evanston Advisors opened 13 new positions and closed 5 in Q2 2017.
- Evanston Advisors's portfolio value rose 10% quarter-over-quarter to $407M.
Based on Evanston Advisors's 13F filing for Q2 2017, filed 9 Aug 2017.